Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2019. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3739362014 | Product containing only crizotinib in oral dose form (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3739363016 | Crizotinib only product in oral dose form | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 5555601000241110 | produit contenant seulement du crizotinib sous forme orale | fr | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT Switzerland NRC maintained Module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing only crizotinib in oral dose form (medicinal product form) | Count of base of active ingredient | un | false | Inferred relationship | Some | ||
| Product containing only crizotinib in oral dose form (medicinal product form) | Is a | Crizotinib-containing product in oral dose form | true | Inferred relationship | Some | ||
| Product containing only crizotinib in oral dose form (medicinal product form) | Has active ingredient | Crizotinib (substance) | true | Inferred relationship | Some | 1 | |
| Product containing only crizotinib in oral dose form (medicinal product form) | Is a | Product containing only crizotinib (medicinal product) | true | Inferred relationship | Some | ||
| Product containing only crizotinib in oral dose form (medicinal product form) | Has manufactured dose form | Oral dose form | true | Inferred relationship | Some | ||
| Product containing only crizotinib in oral dose form (medicinal product form) | Plays role | Antineoplastic therapeutic role | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Crizotinib 250 mg oral capsule | Is a | True | Product containing only crizotinib in oral dose form (medicinal product form) | Inferred relationship | Some | |
| Product containing precisely crizotinib 200 milligram/1 each conventional release oral capsule (clinical drug) | Is a | True | Product containing only crizotinib in oral dose form (medicinal product form) | Inferred relationship | Some |
This concept is not in any reference sets
FHIR